Kumaresan Ganesan

7PUBLICATIONS
35CO-AUTHORS
Molecular targetsHuman rights and justice issues (excl. law)Cancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Mar 19, 2023
PI3K/AKT/mTOR inhibitors as potential extracellular matrix modulators for targeting EMT subtype gastric tumors.

Ponmathi Panneerpandian, Kumaresan Ganesan

|Aug 20, 2022
OCT4-mediated transcription confers oncogenic advantage for a subset of gastric tumors with poor clinical outcome.

Jaishree Pandian, Ponmathi Panneerpandian, Balaji T Sekar

|Jun 20, 2022
Identification of oncogenic signaling pathways associated with the dimorphic metabolic dysregulations in gastric cancer subtypes.

Karthik Balakrishnan, Kumaresan Ganesan

|Oct 21, 2021
Ethics of DNA research on human remains: five globally applicable guidelines.

Songül Alpaslan-Roodenberg, David Anthony, Hiba Babiker

|May 18, 2021
Identification of kinases and kinase inhibitors for the differential targeting of Wnt/β-catenin signaling in gastric cancer subtypes.

Divya Bhaskar Rao, Helen Jemimah Devanandan, Kumaresan Ganesan

|Sep 19, 2020
Occurrence of differing metabolic dysregulations, a glucose driven and another fatty acid centric in gastric cancer subtypes.

Karthik Balakrishnan, Kumaresan Ganesan

Pageof 2